相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inducible Deletion of YAP and TAZ in Adult Mouse Smooth Muscle Causes Rapid and Lethal Colonic Pseudo-Obstruction
Fatima Daoud et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation
Valeria Canu et al.
CELL DEATH AND DIFFERENTIATION (2021)
Cancer statistics for the year 2020: An overview
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Emerging Principles in the Transcriptional Control by YAP and TAZ
Alejandro Lopez-Hernandez et al.
CANCERS (2021)
Tumor microenvironment components: Allies of cancer progression
Pablo Igor Ribeiro Franco et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
Barry J. Thompson
BIOESSAYS (2020)
Regulation of Hippo Signaling by Mechanical Signals and the Cytoskeleton
Cong Zhang et al.
DNA AND CELL BIOLOGY (2020)
Cooperation Between MYC and β-Catenin in Liver Tumorigenesis Requires Yap/Taz
Andrea Bisso et al.
HEPATOLOGY (2020)
YAP/TAZ functions and their regulation at a glance
Arianna Pocaterra et al.
JOURNAL OF CELL SCIENCE (2020)
Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
Sandra Munoz-Galvan et al.
MOLECULAR CANCER (2020)
Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers
Rui Wei et al.
ANALYTICAL CELLULAR PATHOLOGY (2020)
Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
Raluca Ioana Teleanu et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Dysfunctional Mechanotransduction through the YAP/TAZ/Hippo Pathway as a Feature of Chronic Disease
Mathias Cobbaut et al.
CELLS (2020)
Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
Sharmilla Devi Jayasingam et al.
FRONTIERS IN ONCOLOGY (2020)
Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis
Daniela M. Santos et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Systematic analysis of the Hippo pathway organization and oncogenic alteration in evolution
Yuxuan Chen et al.
SCIENTIFIC REPORTS (2020)
Yap suppresses T-cell function and infiltration in the tumor microenvironment
Eleni Stampouloglou et al.
PLOS BIOLOGY (2020)
Modulation of YAP/ TAZ by statins to improve survival in epithelioid hemangioendothelioma (EHE).
Aparna Subramaniam et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma
Hirofumi Omori et al.
SCIENCE ADVANCES (2020)
Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?
Sarah Morice et al.
CANCERS (2020)
The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis
Heinrich Kovar et al.
CELLS (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment
Wenjie Yang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization
Xiaoping Zhao et al.
EXPERIMENTAL CELL RESEARCH (2020)
A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations
Hirohito Yamaguchi et al.
FRONTIERS IN ONCOLOGY (2020)
New Insights Into the Role of Phenotypic Plasticity and EMT in Driving Cancer Progression
Sugandha Bhatia et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer
Michal Shreberk-Shaked et al.
CANCER RESEARCH (2020)
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
Ajaybabu Pobbati et al.
THERANOSTICS (2020)
F-actin dynamics regulates mammalian organ growth and cell fate maintenance
Arianna Pocaterra et al.
JOURNAL OF HEPATOLOGY (2019)
Hippo pathway as another oncogenic mediator to promote immune evasion by PD-L1 signaling
Sook-Hee Hong
JOURNAL OF THORACIC DISEASE (2019)
WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis
Yu-An Chen et al.
FRONTIERS IN ONCOLOGY (2019)
A brief review: some compounds targeting YAP against malignancies
Zhenxue Tang et al.
FUTURE ONCOLOGY (2019)
Context-dependent EMT programs in cancer metastasis
Nicole M. Aiello et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
SOX9 promotes epithelial-mesenchymal transition via the Hippo-YAP signaling pathway in gastric carcinoma cells
Hailang Zhou et al.
ONCOLOGY LETTERS (2019)
The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
Taha Azad et al.
CELLS (2019)
Role of the Hippo Pathway in Fibrosis and Cancer
Cho-Long Kim et al.
CELLS (2019)
y Cell competition: the winners and losers of fitness selection
Sarah Bowling et al.
DEVELOPMENT (2019)
The Emerging Role of YAP/TAZ in Tumor Immunity
Zhaoji Pan et al.
MOLECULAR CANCER RESEARCH (2019)
Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice
Fang Hao et al.
PLOS ONE (2019)
The VEGF receptor neuropilin 2 promotes homologous recombination by stimulating YAP/TAZ-mediated Rad51 expression
Ameer L. Elaimy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
Gandhi T. K. Boopathy et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling
Grace E. Coggins et al.
CANCER RESEARCH (2019)
Control of cellular responses to mechanical cues through YAP/TAZ regulation
Ishani Dasgupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment
Jingjing Lu et al.
JOURNAL OF BIOMEDICAL OPTICS (2019)
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis
Zhijun Liu et al.
JOURNAL OF CELL SCIENCE (2019)
TAZ Expression on Endothelial Cells Is Closely Related to Blood Vascular Density and VEGFR2 Expression in Astrocytomas
Chenyue Xu et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2019)
Mesenchymal-epithelial transition in development and reprogramming
Duanqing Pei et al.
NATURE CELL BIOLOGY (2019)
The complex entanglement of Hippo-Yap/Taz signaling in tumor immunity
Shannon M. White et al.
ONCOGENE (2019)
Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts
Nicola Ferrari et al.
NATURE COMMUNICATIONS (2019)
Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
Karla Santos-de-Frutos et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma
Jason W. Lui et al.
JOURNAL OF CANCER (2019)
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Philamer C. Calses et al.
TRENDS IN CANCER (2019)
YAP/TAZ Signaling and Resistance to Cancer Therapy
Chan D. K. Nguyen et al.
TRENDS IN CANCER (2019)
YAP and TAZ: a signalling hub of the tumour microenvironment
Francesca Zanconato et al.
NATURE REVIEWS CANCER (2019)
The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1
Helena J. Janse van Rensburg et al.
CANCER RESEARCH (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome
Andrew D. Redfern et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
YAP and TAZ are essential for basal and squamous cell carcinoma initiation
Maud Debaugnies et al.
EMBO REPORTS (2018)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Cyclizing-berberine A35 induces G2/M arrest and apoptosis by activating YAP phosphorylation (Ser127)
Wuli Zhao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Epithelial Mesenchymal Transition in Tumor Metastasis
Vivek Mittal
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
The Hippo pathway in normal development and cancer
Marcello Maugeri-Sacca et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Verteporfin enhances the sensitivity of LOVO/TAX cells to taxol via YAP inhibition
Ganggang Shi et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity
Xuhao Ni et al.
CANCER DISCOVERY (2018)
A tightly controlled Src-YAP signaling axis determines therapeutic response to dasatinib in renal cell carcinoma
Jingya Sun et al.
THERANOSTICS (2018)
The Role of Dll4/Notch Signaling in Normal and Pathological Ocular Angiogenesis: Dll4 Controls Blood Vessel Sprouting and Vessel Remodeling in Normal and Pathological Conditions
Ivan Lobov et al.
JOURNAL OF OPHTHALMOLOGY (2018)
YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
Min Hwan Kim et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Unraveling the Role of Angiogenesis in Cancer Ecosystems
Iratxe Zuazo-Gaztelu et al.
FRONTIERS IN ONCOLOGY (2018)
The Hippo Signaling Network and Its Biological Functions
Jyoti R. Misra et al.
ANNUAL REVIEW OF GENETICS, VOL 52 (2018)
Interplay between YAP/TAZ and Metabolism
Ja Hyun Koo et al.
CELL METABOLISM (2018)
The role of YAP/TAZ activity in cancer metabolic reprogramming
Xiaodong Zhang et al.
MOLECULAR CANCER (2018)
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
Francesca Zanconato et al.
NATURE MEDICINE (2018)
VEGF-neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP β2-chimaerin
Ameer L. Elaimy et al.
SCIENCE SIGNALING (2018)
The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors
Thijs J. Hagenbeek et al.
SCIENCE SIGNALING (2018)
Cancer cell plasticity: Impact on tumor progression and therapy response
Victoria da Silva-Diz et al.
SEMINARS IN CANCER BIOLOGY (2018)
A feed forward loop enforces YAP/TAZ signaling during tumorigenesis
Mandeep K. Gill et al.
NATURE COMMUNICATIONS (2018)
Convergence of VEGF and YAP/TAZ signaling: Implications for angiogenesis and cancer biology
Ameer L. Elaimy et al.
SCIENCE SIGNALING (2018)
Clinical implications of the Hippo-YAP pathway in multiple cancer contexts
Han-Byul Kim et al.
BMB REPORTS (2018)
Regulation of the Hippo signaling pathway by ubiquitin modification
Youngeun Kim et al.
BMB REPORTS (2018)
Multifaceted regulation and functions of YAP/TAZ in tumors
Huirong Liu et al.
ONCOLOGY REPORTS (2018)
The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer
Ping-Chih Hsu et al.
BIOMEDICINES (2018)
Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration
Li Lu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Regulation of Hippo signaling by actin remodeling
Jimyung Seo et al.
BMB REPORTS (2018)
Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies
Min Hwan Kim et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Targeted Disruption of YAP and TAZ Impairs the Maintenance of the Adrenal Cortex
Adrien Levasseur et al.
ENDOCRINOLOGY (2017)
Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer
Hsiang-Hsi Ling et al.
EXPERIMENTAL CELL RESEARCH (2017)
VEGF as a potential target in lung cancer
Daniela Frezzetti et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Yan-Jiun Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
The Role of PDGFs and PDGFRs in Colorectal Cancer
RobertaM. Manzat Saplacan et al.
MEDIATORS OF INFLAMMATION (2017)
Epithelial-to-mesenchymal transition in tumor progression
Elena Prieto-Garcia et al.
MEDICAL ONCOLOGY (2017)
Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells
G-A Franzetti et al.
ONCOGENE (2017)
The Glycolytic Switch in Tumors: How Many Players Are Involved?
Li Yu et al.
JOURNAL OF CANCER (2017)
Hippo pathway in lung development
Yuyuan Dai et al.
JOURNAL OF THORACIC DISEASE (2017)
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC
Elena Ghiso et al.
NEOPLASIA (2017)
Mevalonate Pathway and Human Cancers
Seyedeh Zahra Bathaie et al.
CURRENT MOLECULAR PHARMACOLOGY (2017)
JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity
Juan Ye et al.
CANCER RESEARCH (2017)
The Hippo pathway in organ development, homeostasis, and regeneration
Vivian Fu et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Claire Viallard et al.
ANGIOGENESIS (2017)
YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis
Chunli Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcilloma
Byung Soo Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway
Floriane Gibault et al.
CHEMMEDCHEM (2017)
YAP-1 Promotes Tregs Differentiation in Hepatocellular Carcinoma by Enhancing TGFBR2 Transcription
Ye Fan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure
Monica Schwartzman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Guocan Wang et al.
CANCER DISCOVERY (2016)
Wnt Signaling Promotes Breast Cancer by Blocking ITCH-Mediated Degradation of YAP/TAZ Transcriptional Coactivator WBP2
Shen Kiat Lim et al.
CANCER RESEARCH (2016)
Induction of Expandable Tissue-Specific Stem/Progenitor Cells through Transient Expression of YAP/TAZ
Tito Panciera et al.
Cell Stem Cell (2016)
Cancer: The Transforming Power of Cell Competition
Jesus Gil et al.
CURRENT BIOLOGY (2016)
Cell Competition Drives the Growth of Intestinal Adenomas in Drosophila
Saskia J. E. Suijkerbuijk et al.
CURRENT BIOLOGY (2016)
Non-Photoinduced Biological Properties of Verteporfin
Floriane Gibault et al.
CURRENT MEDICINAL CHEMISTRY (2016)
YAP/TAZ as therapeutic targets in cancer
Francesca Zanconato et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Characterization of Hippo Pathway Components by Gene Inactivation
Steven W. Plouffe et al.
MOLECULAR CELL (2016)
Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style
Allyson J. Merrell et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Control of YAP/TAZ Activity Metabolic anc Nutrient-Sensing Pathways
Giulia Santinon et al.
TRENDS IN CELL BIOLOGY (2016)
Verteporfin, a suppressor of YAP-TEAD complex, presents promising antitumor properties on ovarian cancer
Juntao Feng et al.
ONCOTARGETS AND THERAPY (2016)
Overexpression of TAZ promotes cell proliferation, migration and epithelial-mesenchymal transition in ovarian cancer
Guangyuan Chen et al.
ONCOLOGY LETTERS (2016)
Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations
Dilek Keskin et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Pathophysiological Basis for the Formation of the Tumor Microenvironment
Michael R. Horsman et al.
FRONTIERS IN ONCOLOGY (2016)
The interplay between cell signalling and the mevalonate pathway in cancer
Peter J. Mullen et al.
NATURE REVIEWS CANCER (2016)
The role of 6-phosphofructo-2-kinase (PFK-2)/fructose 2,6-bisphosphatase (FBPase-2) in metabolic reprogramming of cancer cells
Kinga A. Kocemba et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2016)
Alternative Wnt Signaling Activates YAP/TAZ
Hyun Woo Park et al.
CELL (2015)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
Targeting the Hippo Pathway for Anti-cancer Therapies
Rui Gong et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Aerobic glycolysis tunes YAP/TAZ transcriptional activity
Elena Enzo et al.
EMBO JOURNAL (2015)
A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells
Cheng Chang et al.
GENES & DEVELOPMENT (2015)
YAP/TAZ for cancer therapy: Opportunities and challenges
Liwen Guo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment
Matteo Santucci et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer
Zhongwu Li et al.
MOLECULAR ONCOLOGY (2015)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
YAP and TAZ: a nexus for Hippo signaling and beyond
Carsten Gram Hansen et al.
TRENDS IN CELL BIOLOGY (2015)
Signal Transduction in Cancer
Richard Sever et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers
Yusuke Oku et al.
FEBS OPEN BIO (2015)
TAZ promotes epithelial to mesenchymal transition via the upregulation of connective tissue growth factor expression in neuroblastoma cells
Qiang Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Shi Jiao et al.
CANCER CELL (2014)
Deletion of Yes-Associated Protein ( YAP) Specifically in Cardiac and Vascular Smooth Muscle Cells Reveals a Crucial Role for YAP in Mouse Cardiovascular Development
Yong Wang et al.
CIRCULATION RESEARCH (2014)
The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
Xaralabos Varelas
DEVELOPMENT (2014)
YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth
Boon Chuan Low et al.
FEBS LETTERS (2014)
Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition
Maren Diepenbruck et al.
JOURNAL OF CELL SCIENCE (2014)
The Hippo-YAP signaling pathway and contact inhibition of growth
Barry M. Gumbiner et al.
JOURNAL OF CELL SCIENCE (2014)
Metabolic control of YAP and TAZ by the mevalonate pathway
Giovanni Sorrentino et al.
NATURE CELL BIOLOGY (2014)
THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND
Stefano Piccolo et al.
PHYSIOLOGICAL REVIEWS (2014)
Tumor and the Microenvironment: A Chance to Reframe the Paradigm of Carcinogenesis?
Mariano Bizzarri et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Molecular Pathways: YAP and TAZ Take Center Stage in Organ Growth and Tumorigenesis
Stefano Piccolo et al.
CLINICAL CANCER RESEARCH (2013)
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
Fernando Calvo et al.
NATURE CELL BIOLOGY (2013)
Mutual regulation between Hippo signaling and actin cytoskeleton
Yurika Matsui et al.
PROTEIN & CELL (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
The tumor microenvironment at a glance
Frances R. Balkwill et al.
JOURNAL OF CELL SCIENCE (2012)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
分享论文
